- Izea Inc IZEA shares jumped 43.3 percent to $6.94 after jumping 51.56 percent on Monday. IZEA disclosed that it has been awarded several contracts.
- CareDx Inc CDNA shares surged 30 percent to $4.33.
- Actua Corp ACTA shares gained 23.7 percent to $15.15 after the company agreed to sell 3 businesses for $549 million.
- Moleculin Biotech Inc MBRX shares surged 20.9 percent to $2.91 after the company disclosed that it has received the FDA approval for its Annamycin IND.
- Greenhill & Co., Inc. GHL shares climbed 15.3 percent to $16.60 after the company disclosed outline of recap plan and share repurchase.
- Seven Stars Cloud Group Inc SSC shares gained 14.9 percent to $2.36.
- AcelRx Pharmaceuticals Inc ACRX shares rose 12.2 percent to $4.38.
- Amphastar Pharmaceuticals Inc AMPH climbed 8.9 percent to $17.72 after the company reported the FDA approval for its ANDA for Neostigmine Methylsulfate Injection, USP.
- ITUS Corp ITUS shares gained 8.8 percent to $4.19.
- Helios and Matheson Analytics Inc HMNY shares jumped 7 percent to $8.88 after surging 19.08 percent on Monday.
- Chromadex Corp CDXC gained 6.4 percent to $4.59 after the company reported top-line results from its second human clinical trial.
- Ascena Retail Group Inc ASNA shares rose 5.5 percent to $2.29 after the company posted stronger-than-expected results for its fourth quarter.
- L Brands Inc LB gained 5.2 percent to $43.01. Atlantic Equities upgraded L Brands from Neutral to Overweight.
- Alder Biopharmaceuticals Inc ALDR rose 5 percent to $11.7. Cowen & Co. initiated coverage on Alder Biopharmaceuticals with an Outperform rating.
- Boston Beer Company Inc SAM gained 4.5 percent to $159.80. Credit Suisse upgraded Boston Beer from Underperform to Neutral.
- Dova Pharmaceuticals Inc DOVA climbed 4.5 percent to $23.46. Leerink Swann upgraded Dova Pharmaceuticals from Market Perform to Outperform.
- Red Hat Inc RHT rose 4.3 percent to $110.28 after the company reported better-than-expected results for its second quarter and raised its guidance for the year.
- FactSet Research Systems Inc. FDS shares gained 3.7 percent to $177.14 a the company reported better-than-expected earnings for its fourth quarter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in